急性肺损伤市场增长、规模、份额、趋势、关键参与者分析及 2028 年预测

  • Report Code : TIPRE00015798
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 141
Buy Now

 

急性肺损伤市场规模预计将从 2021 年的 5.3961 亿美元增至 2028 年的 7.4198 亿美元;预计 2021 年至 2028 年的复合年增长率为 4.7%。

 

急性肺损伤 (ALI) 是危重不健康患者的一种危及生命的疾病。在急性肺损伤疾病中,肺部发生急性炎症,导致肺内皮和上皮屏障破坏。肺泡毛细血管膜由微血管内皮、间质和肺泡上皮组成。急性肺损伤市场是根据危重患者出现非心源性肺水肿和呼吸衰竭进行临床诊断的。其发病率正常;它很可能存在于重症监护环境之外,因此是一种与所有临床医生相关的疾病。

报告对急性肺损伤市场提供了深刻见解和深入分析,强调了各种参数,例如市场趋势、技术进步、市场动态以及全球主要市场参与者的竞争格局分析。它还包括 COVID-19 大流行对所有地区市场的影响。COVID-19 大流行扰乱了世界各国的社会经济状况。根据世界卫生组织最近的统计数据,目前,美国是受 COVID-19 疫情影响最严重的国家,确诊病例和死亡人数最多。大量的 COVID 病例对该国和该地区的经济产生了负面影响。该地区各行各业的整体商业活动和增长都有所下降。

然而,急性肺损伤市场参与者正在启动临床试验,以开发治疗急性肺损伤的药物。例如,生物制药公司 Chimerix 于 2020 年 6 月启动了一项 II/III 期临床试验,以评估 Dociparstat 钠 (DSTAT) 对因 COVID-19 导致的急性肺损伤 (ALI) 患者的安全性和有效性。此外,Altasciences 很高兴支持 ReAlta Life Sciences 开展一项 I 期试验,以评估 RLS-0071 对因 COVID-19、呼吸道合胞病毒 (RSV) 和流感等病毒感染导致的急性肺损伤 (ALI) 的效果。与 COVID-19 相关的问题推动了该地区急性肺损伤市场的增长。

根据地区,市场分为北美、欧洲、亚太、中东和非洲以及南美和中美。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

急性肺损伤市场:

急性肺损伤市场
  • Acute Lung Injury Market
    复合年增长率(2021 - 2028 年)
    4.7%
  • 2021 年市场规模
    5.3961 亿美元
  • 2028 年市场规模
    7.4198 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • 葛兰素史克公司
  • Stemedica细胞技术公司
  • 组织细胞
  • APEPTICO 研究与开发有限公司
  • Windtree Therapeutics, Inc.
  • ReAlta 生命科学公司
  • Apeiron Biologics AG
  • Qx Therapeutics, Inc.
  • 安吉奥

区域概况

Acute Lung Injury Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Acute Lung Injury Market治疗
  • 机械通气
  • 液体管理
  • 药物治疗
  • 辅助治疗
Acute Lung Injury Market最终用户
  • 医院
  • 门诊手术中心
  • 其他的
Acute Lung Injury Market地理
  • 北美
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 南美洲和中美洲
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

 

市场洞察

 

 

呼吸系统疾病患病率上升推动急性肺损伤市场发展

 

呼吸系统疾病的高发病率与老年人上呼吸道管腔尺寸减小有关。肺部疾病是全球最常见的疾病之一。根据美国疾病控制与预防中心 (CDC) 的数据,慢性阻塞性肺病 (COPD) 和急性肺损伤 (ALI) 等肺部疾病是美国第三大死亡原因。全世界的人们都患有各种呼吸系统疾病。吸烟、感染和遗传因素是导致呼吸系统疾病的常见因素。COPD、哮喘、慢性支气管炎、囊性纤维化和肺癌等疾病是严重的公共卫生负担。

患有这些呼吸系统疾病的患者通常会呼吸困难。与急性肺损伤或急性呼吸窘迫综合征 (ARDS) 相关的呼吸衰竭是术后死亡的最重要因素之一。

此外,美国疾病预防控制中心、美国食品药品监督管理局 (FDA)、州和地方卫生部门以及其他临床和公共卫生部门继续监测与吸烟或使用电子烟产品相关的肺损伤 (EVALI)。据美国疾病预防控制中心称,截至 2020 年 2 月,全美 50 个州、哥伦比亚特区和两个美国领土(波多黎各和美属维尔京群岛)共记录了 2,807 例住院 EVALI 病例或死亡病例。因此,预计上述所有因素都将导致预测期内急性肺损伤市场的增长。

 

基于治疗的见解

 

根据治疗,急性肺损伤市场细分为机械通气、液体管理、药物治疗和辅助治疗。2021 年,机械通气领域在全球急性肺损伤市场中占据最大市场份额。该领域的增长归因于急性肺损伤 (ALI) 中的机械通气旨在维持氧气,同时避免其毒性和与通气相关的并发症。

 

基于最终用户的洞察

 

根据最终用户,急性肺损伤市场分为医院、门诊手术中心和其他。医院部门在 2021 年占据了最大的市场份额,预计同一部门在预测期内将实现 4.9% 的最高复合年增长率。

急性肺损伤市场参与者采用产品发布和扩张等有机策略来扩大其全球影响力和产品组合并满足日益增长的需求。

 

急性肺损伤市场报告范围

报告属性细节
2021 年市场规模5.3961亿美元
2028 年市场规模7.4198亿美元
全球复合年增长率(2021 - 2028)4.7%
历史数据2019-2020
预测期2022-2028
涵盖的领域通过治疗
  • 机械通气
  • 液体管理
  • 药物治疗
  • 辅助治疗
按最终用户
  • 医院
  • 门诊手术中心
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 葛兰素史克公司
  • Stemedica细胞技术公司
  • 组织细胞
  • APEPTICO 研究与开发有限公司
  • Windtree Therapeutics, Inc.
  • ReAlta 生命科学公司
  • Apeiron Biologics AG
  • Qx Therapeutics, Inc.
  • 安吉奥
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

 

通过治疗

 

  • 机械通气
  • 液体管理
  • 药物治疗
  • 辅助治疗

 

按最终用户

 

  • 医院
  • 门诊手术中心
  • 其他的

 

经过

地理

 

  • 北美

    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲

    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区 (APAC)

    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲 (MEA)

    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • MEA 其他地区
  • 南美洲和中美洲(SCAM)

    • 巴西
    • 阿根廷
    • 其余的骗局

 


公司简介

 

  • 葛兰素史克公司
  • Stemedica细胞技术公司
  • 组织细胞
  • APEPTICO 研究与开发有限公司
  • Windtree Therapeutics, Inc.
  • ReAlta 生命科学公司
  • Apeiron Biologics AG
  • Qx Therapeutics, Inc.
  • 安吉奥
  • Asklepion Pharmaceuticals, LLC                                                         
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the key players in the acute lung injury market?

The acute lung injury market majorly consists of players like GlaxoSmithKline plc., Stemedica Cell Technologies, Inc, Histocell, APEPTICO Forschung und Entwicklung GmbH, Windtree Therapeutics, Inc., ReAlta Life Sciences, Inc., Apeiron Biologics AG, Qx Therapeutics, Inc., Angion, and Asklepion Pharmaceuticals, LLC. among others. Histocell and APEPTICO Forschung und Entwicklung GmbH are the top most two companies in the market.

What are the drivers and restraints for the acute lung injury market?

The growth of the market is attributed to increasing prevalence of respiratory diseases, and rising geriatric population drive the market growth. However, high cost of therapies hampers the market growth.

Which is the potential market for the acute lung injury in terms of region?

Asia Pacific is expected to be the fastest growing region and potential market for acute lung injury. Asia Pacific is expected to expand at a high growth rate. The growth of the acute lung injury market in this region is primarily due to high prevalence of this disease, and the rise in healthcare awareness related to the disease diagnosis. Additionally, developing healthcare infrastructure and increasing investments to boost the manufacturing capacities are projected to drive the Asia Pacific acute lung injury market during the forecast period.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Acute Lung Injury Market

  1. GlaxoSmithKline plc.
  2. Stemedica Cell Technologies, Inc
  3. Histocell
  4. APEPTICO Forschung und Entwicklung GmbH
  5. Windtree Therapeutics, Inc.
  6. ReAlta Life Sciences, Inc.
  7. Apeiron Biologics AG
  8. Qx Therapeutics, Inc.
  9. Angion
  10. Asklepion Pharmaceuticals, LLC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.